495 results on '"Sugimoto, Tohru"'
Search Results
2. Supplementary Figure S2 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
3. Data from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
4. Data from Trastuzumab Activates Allogeneic or Autologous Antibody-Dependent Cellular Cytotoxicity against Malignant Rhabdoid Tumor Cells and Interleukin-2 Augments the Cytotoxicity
5. Supplementary Table 1 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
6. Supplementary Table and 3 Figures from Methylation-Associated Silencing of the Nuclear Receptor 1I2 Gene in Advanced-Type Neuroblastomas, Identified by Bacterial Artificial Chromosome Array-Based Methylated CpG Island Amplification
7. Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS
8. Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST)
9. Boron neutron capture therapy as new treatment for clear cell sarcoma: Trial on different animal model
10. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines
11. Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model
12. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
13. Molecular dynamics simulations for glutamate-binding and cleft-closing processes of the ligand-binding domain of GluR2
14. Prenatal and lactational exposure to low-doses of bisphenol A alters adult mice behavior
15. Successful treatment of infants with localized neuroblastoma based on their MYCN status
16. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study
17. Fiber-tracking techniques can predict the degree of neurologic impairment for periventricular leukomalacia
18. $$ {\text{HCO}}^{ - }_{3} $$-dependent NH3 excretion from lungs?
19. A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan
20. A Novel Perforin Gene Mutation in a Japanese Family with Hemophagocytic Lymphohistiocytosis
21. Imaging analysis of mineralocorticoid receptor and importins in single living cells by using GFP color variants
22. Hb Bristol-Alesha Presenting Thalassemia-Type Hyperunstable Hemoglobinopathy
23. Quantum chemical calculation of intrinsic reaction coordinates from trans to cis structure of fluvoxamine
24. Treatment for Leigh syndrome by monitoring dichloroacetate concentration
25. Diversity in neuroblastomas and discrimination of the risk to progress
26. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16
27. SERUM LEVEL OF MYCN AMPLIFICATION IN NEUROBLASTOMA USING TUMOR-RELEASED DNA BY REAL-TIME QUANTITATIVE PCR: O-083
28. Partial tandem duplication of GRIA3 in a male with mental retardation
29. Features and prognoses of infantile patients with atopic dermatitis hospitalized for severe complications
30. SCN1A Mutation Mosaicism in a Family with Severe Myoclonic Epilepsy in Infancy
31. O.086 SPECIFIC INHIBITION OF PAX3-FKHR FUSION GENE IN RHABDOMYOSARCOMA BY SMALL INTERFERING RNA
32. High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis
33. Systemic juvenile idiopathic arthritis mimics multicentric Castleman’s disease
34. Circulating MYCN DNA Predicts MYCN-Amplification in Neuroblastoma
35. OUTCOME OF PATIENTS WITH RHABDOMYOSARCOMA TREATED FROM 1991 TO 2002 IN JAPAN—BETTER SURVIVAL IN HIGH-RISK GROUP-: P.E.023
36. DETERMINATION OF MYCN AMPLIFICATION IN NEUROBLASTOMA USING SERUM DNA BY REAL-TIME QUANTITATIVE PCR: O.122
37. Prediction of MYCN Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain Reaction
38. Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation
39. Use of rituximab to treat refractory Diamond-Blackfan anemia
40. Drug–drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338
41. Infantile Spasms in a Patient with Williams Syndrome and Craniosynostosis
42. Ring Chromosome 14 with Localization-related Epilepsy: Three Cases
43. A novel missense mutation (1060G → C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis
44. Yellow Fluorescent Protein-Tagged and Cyan Fluorescent Protein-Tagged Imaging Analysis of Glucocorticoid Receptor and Importins in Single Living Cells
45. Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan
46. Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement
47. Distal 14q trisomy due to a maternal derivative chromosome 14
48. Voltammetric and spectroelectrochemical characterization of a water-soluble viologen polymer and its application to electron-transfer mediator for enzyme-free regeneration of NADH
49. Newly established Askin tumor cell line and overexpression of focal adhesion kinase in Ewing sarcoma family of tumors cell lines
50. Effect of sex on serum protein binding characteristics of phenytoin in pediatric patients with epilepsy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.